QS Investors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

QS Investors’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,245	Closed	-$270K	–	1707
2019 Q4	$270K	Sell	13,245 -241	-2%	-$3.44K	﹤0.01%	1114
2019 Q3	$193K	Hold	13,486	–	–	﹤0.01%	1214
2019 Q2	$180K	Sell	13,486 -352	-3%	-$5.32K	﹤0.01%	1250
2019 Q1	$241K	Hold	13,838	–	–	﹤0.01%	1160
2018 Q4	$190K	Hold	13,838	–	–	﹤0.01%	1143
2018 Q3	$298K	Hold	13,838	–	–	﹤0.01%	1092
2018 Q2	$593K	Hold	13,838	–	–	0.01%	902
2018 Q1	$903K	Sell	13,838 -914	-6%	-$64.8K	0.01%	806
2017 Q4	$1.08M	Sell	14,752 -749	-5%	-$62K	0.01%	786
2017 Q3	$1.42M	Sell	15,501 -507	-3%	-$38.9K	0.01%	720
2017 Q2	$1.06M	Hold	16,008	–	–	0.01%	769
2017 Q1	$3.47M	Hold	16,008	–	–	0.03%	422
2016 Q4	$1.48M	Sell	16,008 -4,378	-21%	-$493K	0.01%	684
2016 Q3	$2.76M	Buy	20,386 +293	+1%	+$29.1K	0.02%	569
2016 Q2	$2.04M	Buy	+20,093	New	+$2.49M	0.02%	630
2015 Q4	–	Sell	-856	Closed	-$276K	–	2093
2015 Q3	$276K	Sell	856 -1,044	-55%	-$459K	﹤0.01%	1006
2015 Q2	$757K	Buy	+1,900	New	+$807K	0.01%	809

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

QS Investors's LUMO Position: Q1 2020 in Review

QS Investors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 13,245 shares — an estimated $270K sold.

QS Investors first reported a position in LUMO in Q2 2015 and held it in 17 quarters. The position peaked at $3.47M in Q1 2017. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

QS Investors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
QS Investors sold 13,245 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $270K.
QS Investors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
QS Investors's Lumos Pharma, Inc. Common Stock position peaked at $3.47M in Q1 2017.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on QS Investors's 13F filing for Q1 2020, filed 15 May 2020.